4
Changes in Ownership
Avalo Therapeutics, Inc. Filed Acc 0001878894-21-000003
Options or other derivatives
- Chief Executive Officer acquired 78,116 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
COLA MICHAEL F · Chief Executive Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-10-01 | Grant or award : show line 1 in the form Stock Option (Right to Buy) | +78,116 | 78,116 | D |
Loading xslF345X03/edgar.xml…